Portfolio Lab

DIEBOLD NIXDORF, Inc

  • Stock
  • Ticker DBD
  • ISIN US2536512021
  • NYSE

Technology · Computers and communications equipment · USA

$51.86 +3.16%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of DIEBOLD NIXDORF, Inc since 08/2023, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

DBDGlobal equities (VT)

$10,000 grew to $20,195. Global equities (VT): $15,235.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −44.6% in 11/2026, measured from the peak in 07/2026. The old peak has not been reached again yet.

1-year return
−13.6%
Return p.a. since 08/2023
+30.9%
Volatility p.a.
37.4%
Largest decline
−44.6%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue9898419159451,104892931994
Gross profit232202234245280213240247
Operating income4130567482335739
EBITDA79646582113646346
Net income5.6-8.31241505.0166.6
Earnings per share0.15-0.220.331.111.340.140.440.19
Balance sheet
Total assets3,5443,6263,7403,7243,8543,8303,7373,663
Liabilities2,6052,6352,6352,6112,7502,8042,7602,719
Equity9309841,0971,1071,1001,023969936
Cash296307279246369359282185
Long-term debt927929931934939939943949
Cash flow
Operating cash flow19616303721832-14-47
Free cash flow19616303721832-14-47

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2025 at +57.7%, weakest 2024 at +48.7%. 2 of 2 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
28 Oct 2026$0.19
29 Jul 2026$0.44
30 Apr 2026$0.14
12 Feb 2026$1.34
5 Nov 2025$1.11
6 Aug 2025$0.33
7 May 2025−$0.22
25 Feb 2025$0.15
7 Nov 2024−$0.60
7 Aug 2024$0.40
2 May 2024−$0.39
9 Aug 2023−$8.46

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€1.6bn
Market cap in trading currency
$1.74bn
Enterprise value
$2.51bn
P/E
24.6
P/S
0.44
P/B
1.86
EV/Sales
0.64
EV/EBITDA
8.8
Earnings yield
4.1%
FCF yield
10.8%

Results (last four quarters)

Revenue
$3.92bn
Gross profit
$980m
EBITDA
$286m
Net income
$76.7m
Earnings per share
$2.11
Revenue per share
$116.75
Revenue growth
+5.2%
Earnings growth
−83.9%

Profitability

Gross margin
25.0%
Operating margin
5.4%
Net margin
2.0%
Return on equity
7.5%
Return on assets
2.1%

Balance sheet and cash flow

Cash
$185m
Cash per share
$5.51
Financial debt
$949m
Debt/equity %
101
Current ratio
1.27
Book value per share
$27.87
Operating cash flow
$188m
Free cash flow
$188m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
33.6m
Volume
515,330
Avg. volume 3 months
292,249
Relative volume
1.8

Price and technicals

Price
$51.86
1 day
+3.2%
52-week high
$90.75
52-week low
$50.27
Distance to 52-week high
−42.9%
Distance to 52-week low
+3.2%
Distance to 50-day line
−15.7%
Distance to 200-day line
−29.8%
RSI (14)
33
Volatility 1M
64.4%

Performance

1 week
−5.8%
1 month
−25.1%
3 months
−24.6%
6 months
−30.2%
YTD
−23.6%
1 year
−16.6%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has DBD performed since 08/2023?

$10,000 grew to $24,121 by 20 Nov 2026, which is +30.9% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is DBD?

Volatility was 37.4% per year, measured on monthly returns. The largest decline from a peak was −44.6%, with the low in 11/2026.

How does DBD compare with a broad equity ETF?

Over the same period Global equities (VT) returned +14.7% per year at 13.1% volatility, DBD returned +30.9% at 37.4%. The correlation of monthly returns was 0.52; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

DIEBOLD NIXDORF, Inc (DBD): Return and risk | Portfolio Lab